MAM-20.101

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameMAM-20.101
Drug Alias NameMAM-20.101MAM-1004-2MAM20.101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsGastritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustria
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMarinomed Biotech AGMedical University Of Vienna
China Registration ClassN/A

Develop Information

Active CompaniesMarinomed Biotech AG
Inactive CompaniesN/A
Active IndicationsGastritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A